Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting Nov 1, 2023
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments Aug 10, 2023
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore Jul 11, 2023
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments May 11, 2023
